Gene · 910
CD1B: CD1b molecule
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CD1B: CD1b molecule. Genes, record 910. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/910
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P29016 | T-cell surface glycoprotein CD1b | 333 | 28 | Ensembl, GeneID, HGNC |
Source UniProt
Patents34
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40466 | P29016 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 780 | P29016 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 780 | P29016 | Espacenet |
| EP 4487869 A2 | 2025-01-08 | 59 | P29016 | Espacenet |
| KR 1020240027895 A | 2024-03-04 | 251 | P29016 | Espacenet |
| JP 2023036863 A | 2023-03-14 | 251 | P29016 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 12945 | P29016 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 2456 | P29016 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 115916 | P29016 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 1800 | P29016 | Espacenet |
1 to 10 of 34
See all 34 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,440
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CD1B papers | Newest fiscal year |
|---|---|---|---|
| R01AI049313 | T cell responses to CD1-restricted lipids in tuberculosis | 54 | 2025 |
| R01AI045889 | Precision Targeting of CD1-Restricted iNKT Cells for Cancer Immunotherapy | 18 | 2025 |
| R01AI022553 | Molecular Analysis of Host Immune Response in Leprosy | 15 | 2025 |
| R01AR040312 | CD1-restricted T-cell Responses in Skin | 15 | 2025 |
| P30AR069625 | Human Skin Disease Resource-based Center | 6 | 2025 |
| R01DK044319 | Characterization of Mucosal Lymphocytes | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| R01AI146072 | The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis | 5 | 2025 |
| R01GM049758 | Structure and Function of Metalloenzymes | 5 | 2025 |
| R24AI059830 | A Xenopus Laevis Research Resource for Immunobiology | 5 | 2025 |
1 to 10 of 1,440Source NIH's project files
See all 1,440 nih grantsPapers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying dendritic cell heterogeneity and potential risk genes in atopic dermatitis: integrative scRNA-seq, bulk RNA-seq analyses and experimental validation. | Front Med (Lausanne) | 2026 | 42718499 | PubTator, text mining | PubMed |
| Integrated experimental and computational evaluation of atractylenolide III from Tubipora musica for anticancer lead identification. | Sci Rep | 2026 | 42716976 | PubTator, text mining | PubMed |
| In vitro differentiation and phenotypic profiling of Langerhans cell subsets derived from human peripheral blood monocytes. | Immunol Res | 2026 | 42704586 | PubTator, text mining | PubMed |
| Newly customized cationic ẞ-cyclodextrins as potential nanovectors for gene delivery. | Int J Pharm | 2026 | 41916514 | PubTator, text mining | PubMed |
| Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering. | Cells | 2026 | 41892285 | PubTator, text mining | PubMed |
| Oligomeric lactic acid nanoplastics induce intrauterine growth restriction in mice by disrupting GATA2-mediated placental vascular development. | PLoS Biol | 2026 | 41886399 | PubTator, text mining | PubMed |
| Mechanistic insights into the therapeutic properties of delta opioid receptor. | Sci Adv | 2026 | 41880505 | PubTator, text mining | PubMed |
| Whole transcriptome sequencing identifies key characteristics and potential therapeutic efficacy biomarkers CD1B, CD247, and CCNB1 in cured tuberculosis patients. | Int J Infect Dis | 2026 | 41871736 | PubTator, text mining | PubMed |
| Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment. | Int J Nanomedicine | 2026 | 41783547 | PubTator, text mining | PubMed |
| Correction: Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses. | Front Immunol | 2026 | 41766885 | PubTator, text mining | PubMed |
1 to 10 of 2,023
See all 2,023 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/910
GET https://conductscience.org/api/genes/v1/910/patents?page=2